CN105732381B - 牛樟芝提取物及其制备方法和应用 - Google Patents

牛樟芝提取物及其制备方法和应用 Download PDF

Info

Publication number
CN105732381B
CN105732381B CN201511023602.XA CN201511023602A CN105732381B CN 105732381 B CN105732381 B CN 105732381B CN 201511023602 A CN201511023602 A CN 201511023602A CN 105732381 B CN105732381 B CN 105732381B
Authority
CN
China
Prior art keywords
cancer
hexane
ethyl acetate
pharmaceutical composition
silica gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201511023602.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN105732381A (zh
Inventor
刘琼琳
蔡潍泽
谢凯欣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oneness Biotech Co Ltd
Original Assignee
Oneness Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oneness Biotech Co Ltd filed Critical Oneness Biotech Co Ltd
Publication of CN105732381A publication Critical patent/CN105732381A/zh
Application granted granted Critical
Publication of CN105732381B publication Critical patent/CN105732381B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12—Acetic acid esters
    • C07C69/21—Acetic acid esters of hydroxy compounds with more than three hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/64—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C07C45/79—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/527—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings
    • C07C49/577—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/56—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN201511023602.XA 2014-12-30 2015-12-30 牛樟芝提取物及其制备方法和应用 Active CN105732381B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462098177P 2014-12-30 2014-12-30
US62/098,177 2014-12-30

Publications (2)

Publication Number Publication Date
CN105732381A CN105732381A (zh) 2016-07-06
CN105732381B true CN105732381B (zh) 2021-07-20

Family

ID=56163420

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201511023602.XA Active CN105732381B (zh) 2014-12-30 2015-12-30 牛樟芝提取物及其制备方法和应用

Country Status (9)

Country Link
US (1) US9884801B2 (enExample)
EP (1) EP3240772B1 (enExample)
JP (1) JP6896630B2 (enExample)
CN (1) CN105732381B (enExample)
ES (1) ES2869904T3 (enExample)
MY (1) MY173104A (enExample)
PL (1) PL3240772T3 (enExample)
TW (1) TWI648257B (enExample)
WO (1) WO2016107582A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106063800B (zh) * 2016-08-01 2020-02-18 上海交通大学 牛樟芝在抗前列腺增生药物中的应用
CN110088073B (zh) 2016-11-18 2023-01-10 国鼎生物科技股份有限公司 用于治疗特应性皮炎的方法和组合物
CN108409571A (zh) * 2018-03-23 2018-08-17 中国药科大学 从金刚纂中提取的用于治疗癌症的化合物
AU2020229809B2 (en) * 2019-02-25 2025-02-13 Arjil Biotech Holding Company Limited Method and composition for inhibiting virus infection
CN113831221B (zh) * 2021-09-18 2023-04-07 云南民族大学 一种倍半萜类化合物及其制备方法与应用
CN114487252B (zh) * 2021-12-28 2024-03-26 陕西嘉禾生物科技股份有限公司 一种用于区别牛樟芝和牛樟木的薄层色谱鉴别方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101417934A (zh) * 2007-10-24 2009-04-29 国鼎生物科技股份有限公司 分离自牛樟芝萃取物的新化合物
CN103221373A (zh) * 2010-09-20 2013-07-24 国鼎生物科技股份有限公司 用于治疗肺癌的方法和组合物
CN103570531A (zh) * 2012-07-25 2014-02-12 丽丰实业股份有限公司 樟芝菌丝体的化合物及其用途
CN104177240A (zh) * 2013-05-28 2014-12-03 曾卉菱 分离自牛樟芝的化合物、萃取物及其用途
CN104211627A (zh) * 2013-05-29 2014-12-17 曾卉菱 牛樟芝化合物、萃取物及其用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6247838B1 (en) 1998-11-24 2001-06-19 The Boc Group, Inc. Method for producing a liquid mixture having a predetermined concentration of a specified component
US7531627B2 (en) 2003-12-19 2009-05-12 Po-Jung Chien Protein ACA1 of Antrodia camphorata
US7109232B2 (en) 2004-03-08 2006-09-19 Simpson Biotech Co., Ltd. Compounds from Antrodia camphorata having anti-inflammatory and anti-tumor activity
ATE513823T1 (de) 2004-08-17 2011-07-15 Simpson Biotech Co Ltd Mischung und verbindungen von mycelien von antrodia camphorata und deren verwendung
US7601854B2 (en) 2006-10-25 2009-10-13 Kang Jian Biotech Corp., Ltd. Diterpenes from the fruiting body of Antrodia camphorata and pharmaceutical compositions thereof
TW200829234A (en) 2007-01-08 2008-07-16 Golden Biotechnology Corp Antrodia camphorata isophorone extract
TW200918498A (en) * 2007-10-19 2009-05-01 Golden Biotechnology Corp Novel compound isolated from Antrodia camphorate extracts
TW201000112A (en) 2008-06-18 2010-01-01 Mackay Memorial Hospital Use of dehydrosulphurenic acid for inhibiting the growth of cancer cells
EP2717865A4 (en) * 2011-06-10 2014-11-12 Golden Biotechnology Corp METHODS AND COMPOSITIONS FOR THE TREATMENT OF BRAIN CANCER
TWI583376B (zh) * 2013-03-20 2017-05-21 曾卉菱 Compounds isolated from Antelroxicus and their use
JP5908002B2 (ja) * 2013-03-20 2016-04-26 卉菱 曽 ベニクスノキタケに含まれる化合物及びその用途
US9249117B2 (en) * 2014-05-20 2016-02-02 Hui Ling Tseng Use of compounds from Antrodia camphorata in manufacturing medicaments for treating kidney diseases

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101417934A (zh) * 2007-10-24 2009-04-29 国鼎生物科技股份有限公司 分离自牛樟芝萃取物的新化合物
CN103221373A (zh) * 2010-09-20 2013-07-24 国鼎生物科技股份有限公司 用于治疗肺癌的方法和组合物
CN103570531A (zh) * 2012-07-25 2014-02-12 丽丰实业股份有限公司 樟芝菌丝体的化合物及其用途
CN104177240A (zh) * 2013-05-28 2014-12-03 曾卉菱 分离自牛樟芝的化合物、萃取物及其用途
CN104211627A (zh) * 2013-05-29 2014-12-17 曾卉菱 牛樟芝化合物、萃取物及其用途

Also Published As

Publication number Publication date
EP3240772B1 (en) 2021-03-03
JP6896630B2 (ja) 2021-06-30
EP3240772A1 (en) 2017-11-08
TWI648257B (zh) 2019-01-21
EP3240772A4 (en) 2018-08-29
MY173104A (en) 2019-12-26
CN105732381A (zh) 2016-07-06
JP2018507175A (ja) 2018-03-15
TW201623208A (zh) 2016-07-01
US9884801B2 (en) 2018-02-06
US20160185703A1 (en) 2016-06-30
WO2016107582A1 (en) 2016-07-07
ES2869904T3 (es) 2021-10-26
PL3240772T3 (pl) 2021-06-28

Similar Documents

Publication Publication Date Title
CN105732381B (zh) 牛樟芝提取物及其制备方法和应用
CN101392015B (zh) 山茶种子中的三萜皂苷及其制备方法和医药用途
JP2012522022A (ja) 新規サルビアノール酸化合物ｌ、その調製方法及び使用
CN103642887A (zh) 一种雷公藤红素衍生物的制备方法及其产品和应用
CN104892713A (zh) 葫芦素c及其类似物的制备方法与应用
TWI282280B (en) Compounds isolated from gamboge resin having activity in inhibiting the growth of tumor/cancer cells and pharmaceutical compositions comprising the same
CN106176716B (zh) 瑞香烷型二萜化合物pimelotide C的新用途
JP2017105795A (ja) ベニコウジカビ（ｍｏｎａｓｃｕｓ ｐｕｒｐｕｒｅｕｓ）から単離された化合物、その調製方法及び使用
CN115894418B (zh) 蒙古蒿内酯a-f及其药物组合物和其制备方法与应用
CN110437247B (zh) 一种具有保肝护肝作用的混源萜类化合物及其用途
KR20050113440A (ko) 암 예방 및 치료에 유효한 진세노사이드 유도체
KR100564383B1 (ko) 진세노사이드 유도체의 제조방법
CN114533719A (zh) 松香烷型二萜类化合物在制备抗炎药物中的应用
CN117586214B (zh) 乌药烷型倍半萜二聚体及其制备方法和用途
CN106008648B (zh) 加加米宁衍生物及其制备方法及应用
CN110934877A (zh) 过氧麦角甾醇和egfr靶点抗体组合物及其在头颈部鳞状细胞癌上应用
CN110812479A (zh) 没食子酸和egfr靶点抗体组合物及其在肺癌上应用
CN104788528B (zh) 霞草齐墩果烷型五环三萜化合物，含有该化合物的药物组合物及其应用
CN115611796B (zh) 薄荷醇单萜二聚体冷水花醇乙及其在制备抗肿瘤药物中的用途
CN103169713B (zh) 一种甾醇类衍生物在制备抗癌药物中的用途
JP2005314236A (ja) 新規クアシノイド系化合物及びそれらの用途
CN105440047B (zh) 口山酮化合物及其制备方法、药物组合物和用途
CN100582110C (zh) 环己酮类饱和三环（桥环）化合物及其制备方法与用途
JPH0892118A (ja) 狼毒に含まれる抗癌および抗ウィルス性成分の採取法および使用法
CN103800308A (zh) 环菠萝蜜烷型降三萜在制备抗肿瘤药物中的用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant